Highlights
NASDAQ: RVNC       Revance Therapeutics
Last Price Today's Change   Day's Range   Trading Volume
14.08   +0.26 (1.88%)  13.70 - 14.38  174,680

Overview

 
Avg Volume (4 weeks):836,601
4 Weeks Range:11.58 - 15.38
4 Weeks Price Volatility (%):
65.79%
52 Weeks Range:11.58 - 33.83
52 Weeks Price Volatility (%):
11.24%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Revance Therapeutics Inc is a clinical-stage biotechnology company. It is focused on the development, manufacturing, and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic indications. The company's proprietary peptide technology enables delivery of botulinum toxin type A through two investigational drug product candidates, DaxibotulinumtoxinA for Injection (RT002), or RT002 injectable, and DaxibotulinumtoxinA Topical Gel (RT001), or RT001 topical. The Company is pursuing clinical development for RT002 injectable in a broad spectrum of aesthetic and therapeutic indications. It holds rights for all indications of RT002 injectable and RT001 topical, and the pharmaceutical uses of its proprietary peptide technology.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

5502  3298  1154  2358 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 ALNA 0.241+0.05 
 ENDP 0.548+0.082 
 TQQQ 23.59-0.41 
 ISBC 13.87-0.35 
 DIDI 2.29-0.07 
 AMD 73.88-2.59 
 XELA 0.116+0.002 
 SQQQ 59.67+0.83 
 AKBA 0.39+0.037 
 QNRX 0.74+0.29